↓
 

Robert Thong's SciTechStrategy Blog

Business Strategy, Collaborations & Change in Bioscience and Healthcare

Robert Thong's SciTechStrategy Blog
  • Home
  • Speaking & Events
  • Topics
  • About
  • Interventions & Consulting
  • Biopharma R&D Partnerships Book
  • Contact
1 2 >>

Category Archives: Business Strategy

Post navigation

← Older posts

Should your Biotech be Virtual?

Robert Thong's SciTechStrategy Blog Posted on Jul 15th, 2016 by Robert ThongAug 5th, 2016

Many new biotechs start off as virtual companies. But at each stage of development, you always end up asking whether you should stay virtual or build your own in-house wet labs. What are the pros and cons of being virtual? And is there a more pragmatic “semi-virtual” approach?

Continue reading →
Posted in Bioscience Business, Business Strategy, Leadership Agenda | Tagged Business Model, Organizational Development, Small-Medium Enterprises

Is Big Always Best?

Robert Thong's SciTechStrategy Blog Posted on Jun 24th, 2016 by Robert ThongJun 24th, 2016

Many research-stage biotechs and other small to medium-sized enterprises (SMEs) prioritize partnerships with Big Partners or in Big Disease Indications without sufficient consideration of other options. But SMEs need to consider other factors when deciding who to partner their assets with and how. As do large pharmas partnering with SMEs … Continue reading →

Posted in Business Strategy, Collaborations, Leadership Agenda

Lessons from Leicester City’s success for Bioscience SMEs

Robert Thong's SciTechStrategy Blog Posted on May 13th, 2016 by Robert ThongMay 13th, 2016

As the 2015–16 English Premier League football season ends, I reflect on the lessons that smaller/medium sized enterprises (SMEs) can learn from Leicester City’s unlikely victory. In addition, to the usual lessons on how an underdog can triumph over much bigger competitors, I explore three other important lessons that are … Continue reading →

Posted in Bioscience Business, Business Strategy, Leadership Agenda, R&D Management | Tagged Business Model, Small-Medium Enterprises

Leveling the Operational Playing Field in Clinical R&D

Robert Thong's SciTechStrategy Blog Posted on Feb 22nd, 2016 by Robert ThongMar 21st, 2016

Some interesting findings from an industry study on the operational performance drivers in clinical R&D were published earlier this month, many of them challenging established wisdom. In this article, I comment on these findings and look at their implications for both the big pharmas and especially the smaller biopharma SMEs. … Continue reading →

Posted in Business Strategy, Innovation & Prod Devt, R&D Management

Strategic Asset Partnering for Bioscience SMEs—Planned or Opportunistic?

Robert Thong's SciTechStrategy Blog Posted on Sep 1st, 2015 by Robert ThongDec 21st, 2015

Partnering assets with large pharmaceutical, diagnostic or medical device multinationals is a critical part of the business model for many small and medium-sized enterprises (SMEs) in the life sciences. But does it make sense for an SME to have a clearly defined partnering strategy or should it be opportunistic? … Continue reading →

Posted in Business Strategy, Collaborations, Leadership Agenda | Tagged BioPharma, Business Model, Platform Technology, Small-Medium Enterprises, Strategic Initiatives

Generics have come full circle for Big Pharma

Robert Thong's SciTechStrategy Blog Posted on Feb 8th, 2015 by Robert ThongMar 3rd, 2015

Pfizer’s proposed Hospira acquisition is the latest in a long line of deals that have moved generic drugs into the mainstream of Big Pharma corporate strategy. Once seen as threats eating away at their expensively-built revenue streams, generics now have a distinct role in many Big Pharmas’ business models. In … Continue reading →

Posted in Bioscience Business, Business Strategy | Tagged BioPharma, Business Model

How Bioscience Platform Companies mature into Focused Product Businesses

Robert Thong's SciTechStrategy Blog Posted on Jan 24th, 2015 by Robert ThongMar 3rd, 2015

In this final instalment of our 3-part series, we look at bioscience platform companies as they mature into focused product businesses. What drives this transition? What are the key success factors as a focused product business? This article covers in more detail Stage 4 of the lifecycle of bioscience platform … Continue reading →

Posted in Bioscience Business, Business Strategy, Leadership Agenda | Tagged Business Model, Platform Technology, Small-Medium Enterprises

Bioscience Platform Companies as Technology/Service Providers and Hybrid Businesses

Robert Thong's SciTechStrategy Blog Posted on Jan 17th, 2015 by Robert ThongMar 3rd, 2015

In this second instalment of our 3-part series, we look at the adolescent and early adulthood stages of bioscience platform companies. What drives the transition to these stages? What are the key success factors during these stages? This article discusses in more detail Stages 2 and 3 of the lifecycle … Continue reading →

Posted in Bioscience Business, Business Strategy, Leadership Agenda | Tagged Business Model, Platform Technology, Small-Medium Enterprises

Bioscience Platform Companies and their Lifecycle

Robert Thong's SciTechStrategy Blog Posted on Jan 10th, 2015 by Robert ThongMar 3rd, 2015

What are bioscience platform companies? And how do they eventually develop into fully-fledged product businesses? Most industry participants, commentators and investors recognize and understand start-up biotech companies at one extreme, and fully-fledged pharmaceutical and medical device product companies at the other. However bioscience platform companies are neither. They can be … Continue reading →

Posted in Bioscience Business, Business Strategy, Leadership Agenda | Tagged Business Model, Platform Technology, Small-Medium Enterprises

Five Things Managers Need to Know about Strategy

Robert Thong's SciTechStrategy Blog Posted on Dec 18th, 2013 by Robert ThongMar 3rd, 2015

Managers at all levels are increasingly involved in strategy development and execution. With this audience in mind, this article aims to demystify a few common misconceptions and clarify some essential truths about Strategy. … Continue reading →

Posted in Business Strategy, Leadership Agenda

BioPharma R&D Focus Paradigms when Payers are the Customers

Robert Thong's SciTechStrategy Blog Posted on Sep 10th, 2013 by Robert ThongMar 3rd, 2015

Most Pharma companies focus their R&D activities by therapeutic area. But in the New Pharma world of Payers as Customers, does this continue to make sense? In this article, we will look at the history and evolution of therepautic area focus in R&D, highlight today’s new requirements and suggest a pragmatic … Continue reading →

Posted in Bioscience Business, Business Strategy, Innovation & Prod Devt, R&D Management | Tagged BioPharma, Drug Discovery & Development, Organizational Development, Payers & Market Access

Brand Stretching or Brand Destruction? A cautionary tale from a British Post Office counter

Robert Thong's SciTechStrategy Blog Posted on Jul 20th, 2013 by Robert ThongJan 25th, 2015

“Stretching” a brand into new products and services is a well known strategy for generating new revenues. The idea is to exploit customer brand loyalty with new offerings while retaining or even enhancing the original brand values. However it’s not always quite this straightforward, as illustrated with this cautionary Tale … Continue reading →

Posted in Business Strategy, Innovation & Prod Devt | Tagged Business Model, Growth

Post navigation

← Older posts

Robert Thong's SciTechStrategy Blog

RT-2-100

Newcomers click here
for the About page

Connect with Me

Find me at LinkedinFollow me on TwitterEmail me

Recent Articles

  • 3 Drug Development Principles for Smart SMEs Oct 12th, 2016
  • Should your Biotech be Virtual? Jul 15th, 2016
  • Is Big Always Best? Jun 24th, 2016
  • Lessons from Leicester City’s success for Bioscience SMEs May 13th, 2016
  • Conference Impressions from Strategic Alliance Management for Pharma 2016 Apr 22nd, 2016
  • Hidden Risks for Pharma Companies Collaborating with Academia and Small Biotechs Mar 21st, 2016

Tags

Academia Alliance Management BioPharma Business Model Drug Discovery & Development Growth Networks Organizational Development Organizational Renewal Payers & Market Access Platform Technology Project Management R&D+NewProdDevt Small-Medium Enterprises Strategic Initiatives

Archives

© 2015, 2016 Robert Thong
↑